Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Enlivex Ltd. (ENLV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ENLV is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 1 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Enlivex Ltd. reports net income of $1.2B, free cash flow of $-10.5M. ENLV trades on the Nasdaq exchange and files with the SEC under CIK 1596812. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ENLV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Enlivex Ltd. directly from SEC EDGAR.
Net Income
$1.2B
Free Cash Flow
$-10.5M
| Institution | Shares | Value | Reported |
|---|---|---|---|
| SIMPLEX TRADING | 100 | $54.00 | 2026-06-30 |
| SIMPLEX TRADING | 100 | $54.00 | 2026-06-30 |
13F Pro Quality Score
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 1 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.